Page last updated: 2024-10-31

nafamostat and Polyarthritis

nafamostat has been researched along with Polyarthritis in 1 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Research Excerpts

ExcerptRelevanceReference
" The effects of FUT-175 on the development of adjuvant arthritis in rats were studied and compared with those of indomethacin."3.67Effects of FUT-175, a novel synthetic protease inhibitor, on the development of adjuvant arthritis in rats and some biological reactions dependent on complement activation. ( Ino, Y; Iwaki, M; Koshiyama, Y; Oda, M; Sato, T; Suzuki, K, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ino, Y1
Sato, T1
Koshiyama, Y1
Suzuki, K1
Oda, M1
Iwaki, M1

Other Studies

1 other study available for nafamostat and Polyarthritis

ArticleYear
Effects of FUT-175, a novel synthetic protease inhibitor, on the development of adjuvant arthritis in rats and some biological reactions dependent on complement activation.
    General pharmacology, 1987, Volume: 18, Issue:5

    Topics: Animals; Arthritis; Arthritis, Experimental; Benzamidines; Complement Pathway, Classical; Female; Gu

1987